Jeffrey Mosebrook Integra Lifesciences Holdings Corp (IART) insider trading activity

Jeffrey Mosebrook is SVP, Fin & Princ Acct Officer of INTEGRA LIFESCIENCES HOLDINGS CORP. Currently has a direct ownership of 26,923 shares of IART, which is worth approximately $784,536. The most recent transaction as insider was on Mar 12, 2024, when has been sold 347 shares (Common Stock) at a price of $35.88 per share, resulting in proceeds of $12,450. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.9K

0% 3M change

116.44% 12M change

Total Value Held $784,536

Jeffrey Mosebrook Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 12 2024	SELL Payment of exercise price or tax liability	$12,450 $35.88 p/Share	347 Reduced 1.27%	26,923 Common Stock
Mar 11 2024	SELL Payment of exercise price or tax liability	$4,708 $36.22 p/Share	130 Reduced 0.54%	23,860 Common Stock
Mar 11 2024	BUY Grant, award, or other acquisition	-	3,410 Added 11.11%	27,270 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	$10,137 $36.73 p/Share	276 Reduced 1.14%	23,990 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	808 Added 3.22%	24,266 Common Stock
Aug 09 2023	SELL Open market or private sale	$52,329 $44.46 p/Share	1,177 Reduced 4.78%	23,458 Common Stock
Jul 03 2023	BUY Grant, award, or other acquisition	-	12,196 Added 33.11%	24,635 Common Stock

Mar 13 2023	SELL Payment of exercise price or tax liability	$10,732 $52.61 p/Share	204 Reduced 1.61%	12,439 Common Stock
Mar 12 2023	SELL Payment of exercise price or tax liability	$15,385 $52.87 p/Share	291 Reduced 2.25%	12,643 Common Stock
Mar 11 2023	SELL Payment of exercise price or tax liability	$12,847 $52.87 p/Share	243 Reduced 1.84%	12,934 Common Stock
Mar 10 2023	BUY Grant, award, or other acquisition	-	3,088 Added 18.99%	13,177 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	1,537 Added 13.22%	10,089 Common Stock
Dec 08 2022	SELL Open market or private sale	$15,685 $56.22 p/Share	279 Reduced 3.16%	8,552 Common Stock
Aug 02 2022	SELL Open market or private sale	$24,808 $56.77 p/Share	437 Reduced 4.72%	8,831 Common Stock
Mar 13 2022	SELL Payment of exercise price or tax liability	$32,685 $65.11 p/Share	502 Reduced 5.14%	9,268 Common Stock
Mar 12 2022	SELL Payment of exercise price or tax liability	$32,815 $65.11 p/Share	504 Reduced 4.91%	9,770 Common Stock
Mar 11 2022	BUY Grant, award, or other acquisition	-	1,430 Added 12.22%	10,274 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	2,836 Added 24.28%	8,844 Common Stock
Nov 10 2021	SELL Open market or private sale	$49,616 $70.88 p/Share	700 Reduced 10.44%	6,008 Common Stock
Mar 13 2021	SELL Payment of exercise price or tax liability	$13,960 $68.1 p/Share	205 Reduced 2.97%	6,708 Common Stock
Mar 12 2021	BUY Grant, award, or other acquisition	-	1,327 Added 16.1%	6,913 Common Stock
Mar 02 2021	SELL Open market or private sale	$72,685 $68.7 p/Share	1,058 Reduced 15.92%	5,586 Common Stock

Jeffrey Mosebrook

SVP, Fin & Princ Acct Officer

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IART shares.

Notify only if

Value

Insider Trading

Get notified when an Integra Lifesciences Holdings Corp insider buys or sells IART shares.

Notify only if

Operation

Value

Type

News

Receive news related to INTEGRA LIFESCIENCES HOLDINGS CORP

Track Activities on IART

Account